The targeted sequencing market was estimated to be worth USD 4.1 billion globally in 2024, and a compound annual growth rate (CAGR) of 17.3% is anticipated over the course of the forecast period. The market for targeted sequencing is expanding as a result of growing research projects and rising need for early disease identification. It is very useful for diagnosing rare diseases, pharmacogenomics, and finding genetic differences for breeding programs, agricultural enhancement, and increased crop output.

Technological developments in sequencing are lowering the cost of sequencing and boosting its use in research and therapeutic settings. The need for targeted sequencing is being driven by the rising incidence of genetic diseases. The market is expanding as a result of the growing number of research and development initiatives worldwide.

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/targeted-sequencing-market

Growth Drivers

Significant market growth is being driven by ongoing developments in sequencing technology, growing clinical and research use, and the growing applications of genomics across multiple industries. The industry is expanding rapidly due to the significance of genomics in public health response and preparedness. Efficiency, accuracy, and cost-effectiveness have increased due to ongoing developments in next-generation sequencing technologies.

The need for targeted sequencing is being driven by the increased focus on customized medicine, which entails adjusting medical care to each patient's unique genetic traits. It facilitates the development of tailored medicines by allowing the detection of genetic variation linked to disease, drug responses, and treatment results. The market is expanding considerably due to the rising incidence of genetic disorders, autoimmune diseases, and cancer.

Segmentation

Product Type

·         Instruments

·         Services

·         Kits/ Panels

·         Others

By End-User

·         Diagnostic and Clinical Laboratories

·         Academic and Research Institutions

·         Pharmaceutical and Biotech Companies

·         Others

By Application

·         Cancer

·         Reproductive Health

·         Heredity Diseases

·         Neurological Disorders

·         Infectious Diseases

·         Rare Diseases

·         Cardiovascular Diseases

·         Others

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Europe

·         Middle East and Africa

Key Players

·         Illumina

·         Thermo Fisher Scientific

·         Qiagen

·         Agilent Technologies

·         BGI Group

·         Roche

·         Oxford Nanopore Technologies

·         Pacific Biosciences

·         PerkinElmer

·         GenScript

·         Other Players

For More Information about this Report @ https://www.xresearch.biz/shop/targeted-sequencing-market

About Us: -  

xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

Contact:                                           
Company Name:  xResearch
Contact Person:  James Lin
Email:  sales@xresearch.biz
Phone: +1 718-619-8140

Websites: https://www.xresearch.biz/